CAS NO: | 147159-51-1 |
包装 | 价格(元) |
100mg | 电议 |
250mg | 电议 |
500mg | 电议 |
生物活性 | TT-232 (CAP-232), a somatostatin derivative, is a peptideSSTR1/SSTR4agonist. TT-232 inhibitscancercell proliferation and inducesapoptosis. TT-232 is also a broad-spectrum anti-inflammatory and analgesic agent[1][2][4]. | ||||||||
IC50& Target[4] |
| ||||||||
体外研究 (In Vitro) | TT-232 (10 μg/mL, 48 h) induces apoptosis in human colon (HT-29 and SW620), pancreatic (818), leukemia (K-562), melanoma (WM 938/B, M-1 and EP) and lymphoma (HT-58) tumor cell lines[1]. Cell Viability Assay[2]
| ||||||||
体内研究 (In Vivo) | TT-232 (15-750 μg/kg/day, twice a day) inhibits tumor growth in mice transplanted with Colon 26 cell[2].
| ||||||||
Clinical Trial | |||||||||
分子量 | 947.13 | ||||||||
Formula | C45H58N10O9S2 | ||||||||
CAS 号 | 147159-51-1 | ||||||||
运输条件 | Room temperature in continental US; may vary elsewhere. | ||||||||
储存方式 | Please store the product under the recommended conditions in the Certificate of Analysis. |